NSPR Stock Analysis: Buy, Sell, or Hold?
NSPR - InspireMD, Inc.
$0.70
-0.02 (-2.11%)
▼
5d:
-7.76%
30d:
-31.94%
90d:
-59.71%
HOLD
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Get Alerted When NSPR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NSPR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: NSPR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: NSPR is currently trading at $0.70, which is considered oversold relative to its 30-day fair value range of $0.75 to $0.99.
Technical Outlook: Technically, NSPR is in a strong downtrend. The price is currently testing key support at $0.76. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NSPR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.67 (+423.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NSPR is in a strong downtrend. The price is currently testing key support at $0.76. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NSPR has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $3.67 (+423.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.75 -
$0.99
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 423.1% below Wall St target ($3.67)
- CAUTION: Recommendation downgraded due to -7.8% 5-day decline
Trading Range Analysis
30-Day Trading Range
$0.75 -
$0.99
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.76
Resistance Level
$1.04
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.15
Wall Street Target
$3.67
(+423.1%)
Revenue Growth (YoY)
122.2%
Share & Embed Analysis
Last updated: June 24, 2026 12:34 AM ET
Data refreshes hourly during market hours. Next update: 1:34 AM
Data refreshes hourly during market hours. Next update: 1:34 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NSPR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Shane Thomas Gleason
SELL
2000 shares
2026-02-02
Shane Thomas Gleason
SELL
2900 shares
2026-01-30
Shane Thomas Gleason
SELL
5000 shares
2026-01-29
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$77 | 60 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$242 | 61 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 59 HOLD |
